The Quick SARS-CoV-2 Multiplex Kit is a real-time reverse transcription PCR (rRT-PCR) test for the qualitative detection of RNA from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is responsible for the coronavirus disease (COVID-19).
The Quick SARS-CoV-2 Multiplex Kit targets a region of the viral nucleocapsid (N) gene and a host-specific target region (human RNase P gene) to assess sample quality. The kit also includes CV Positive Control that enable assay performance monitoring, and a No-Template Control to confirm the absence of contamination in the reagents.
The Quick SARS-CoV-2 Multiplex Kit can be used on purified RNA samples isolated from upper respiratory and lower respiratory systems.
The Quick SARS-CoV-2 Multiplex Kit has High Sensitivity, with a Limit of Detection as low as 10 viral genome equivalent copies per reaction, a fast turnaround time of less than 2 hours, and a simple workflow in which RNA is simply added to the Quick SARS-CoV-2 Multiplex Kit reagent and directly analyzed.
Due to its simplicity, set-up up can be performed in an automation and it is compatible with high-throughput platforms. The kit is compatible with multiple Real-Time PCR instruments capable of detecting HEX/VIC and Quasar 670/Cy5 fluorophores and technical support is available for all steps of the setup process and data interpretation.
High Sensitivity: Limit of Detection as low as 10 GEC/reaction (167 GEC/ml)
Specific: Detection of SARS-CoV-2 and Emerging Strains (including Omicron)
Rapid & Easy Setup: Ready-to-use Master Mix, just add sample.
Compatible with Automated and High-Throughput workflows.
CE-IVD Marked
DESCRIPTION
The Quick SARS-CoV-2 Multiplex Kit is a real-time reverse transcription PCR (rRT-PCR) test for the qualitative detection of RNA from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is responsible for the coronavirus disease (COVID-19).
The Quick SARS-CoV-2 Multiplex Kit targets a region of the viral nucleocapsid (N) gene and a host-specific target region (human RNase P gene) to assess sample quality. The kit also includes CV Positive Control that enable assay performance monitoring, and a No-Template Control to confirm the absence of contamination in the reagents.
The Quick SARS-CoV-2 Multiplex Kit can be used on purified RNA samples isolated from upper respiratory and lower respiratory systems.
The Quick SARS-CoV-2 Multiplex Kit has High Sensitivity, with a Limit of Detection as low as 10 viral genome equivalent copies per reaction, a fast turnaround time of less than 2 hours, and a simple workflow in which RNA is simply added to the Quick SARS-CoV-2 Multiplex Kit reagent and directly analyzed.
Due to its simplicity, set-up up can be performed in an automation and it is compatible with high-throughput platforms. The kit is compatible with multiple Real-Time PCR instruments capable of detecting HEX/VIC and Quasar 670/Cy5 fluorophores and technical support is available for all steps of the setup process and data interpretation.
In the United States: -This test has not been FDA cleared or approved and it is currently CE IVD marked.
TECHNICAL SPECIFICATIONS
Compatibility
Compatible with automated and high-throughput workflows.
Equipment Required
Real-Time PCR Instruments capable of detecting HEX/VIC and Quasar® 670/Cy5 fluorophores. Adjustments of the RT-PCR parameters may be necessary for instruments different than the CFX96 Touch from Bio-Rad.
Input Quality
Purified RNA free of enzymatic inhibitors.
Processing Time
≤ 2 hours from set up to results.
Reagents
Complete and ready to use master mix.
Registration Status
CE-IVD Marked
Sample Input Material
Purified RNA from upper respiratory and lower respiratory systems.
High Sensitivity: Limit of Detection as low as 10 GEC/reaction (167 GEC/ml)
Specific: Detection of SARS-CoV-2 and Emerging Strains (including Omicron)
Rapid & Easy Setup: Ready-to-use Master Mix, just add sample.
Compatible with Automated and High-Throughput workflows.
CE-IVD Marked
DESCRIPTION
The Quick SARS-CoV-2 Multiplex Kit is a real-time reverse transcription PCR (rRT-PCR) test for the qualitative detection of RNA from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is responsible for the coronavirus disease (COVID-19).
The Quick SARS-CoV-2 Multiplex Kit targets a region of the viral nucleocapsid (N) gene and a host-specific target region (human RNase P gene) to assess sample quality. The kit also includes CV Positive Control that enable assay performance monitoring, and a No-Template Control to confirm the absence of contamination in the reagents.
The Quick SARS-CoV-2 Multiplex Kit can be used on purified RNA samples isolated from upper respiratory and lower respiratory systems.
The Quick SARS-CoV-2 Multiplex Kit has High Sensitivity, with a Limit of Detection as low as 10 viral genome equivalent copies per reaction, a fast turnaround time of less than 2 hours, and a simple workflow in which RNA is simply added to the Quick SARS-CoV-2 Multiplex Kit reagent and directly analyzed.
Due to its simplicity, set-up up can be performed in an automation and it is compatible with high-throughput platforms. The kit is compatible with multiple Real-Time PCR instruments capable of detecting HEX/VIC and Quasar 670/Cy5 fluorophores and technical support is available for all steps of the setup process and data interpretation.
In the United States: -This test has not been FDA cleared or approved and it is currently CE IVD marked.
TECHNICAL SPECIFICATIONS
Compatibility
Compatible with automated and high-throughput workflows.
Equipment Required
Real-Time PCR Instruments capable of detecting HEX/VIC and Quasar® 670/Cy5 fluorophores. Adjustments of the RT-PCR parameters may be necessary for instruments different than the CFX96 Touch from Bio-Rad.
Input Quality
Purified RNA free of enzymatic inhibitors.
Processing Time
≤ 2 hours from set up to results.
Reagents
Complete and ready to use master mix.
Registration Status
CE-IVD Marked
Sample Input Material
Purified RNA from upper respiratory and lower respiratory systems.
Romanian
English
